PCDHA3 activators would be a class of chemical agents specifically formulated to modulate the activity of the protein Protocadherin Alpha 3 (PCDHA3), a member of the protocadherin family which plays a role in the molecular processes of cell-cell adhesion. These proteins are typically involved in the formation and maintenance of precise cellular connections, especially in neural tissues. PCDHA3, like other protocadherins, is thought to contribute to the patterning and wiring of neural networks by mediating homophilic cell adhesion. To design activators for PCDHA3, a deep molecular understanding of the protein's structure, particularly the cadherin repeats that are key to its adhesive functions, would be necessary. The discovery and development of PCDHA3 activators would likely incorporate a combination of computational modeling to predict potential binding sites and molecular interactions, along with empirical approaches such as high-throughput screening to identify molecules that could enhance PCDHA3 activity. These activators would require a high degree of specificity to ensure selective modulation of PCDHA3 without cross-reactivity to other closely related protocadherins.
In the pursuit of PCDHA3 activators, the identified lead compounds would undergo iterative cycles of optimization to improve their binding affinity and selectivity for PCDHA3. Medicinal chemists would modify these molecules, guided by SAR studies that elucidate how structural changes impact function. Additionally, biophysical assays such as calorimetry or fluorescence resonance energy transfer (FRET) could be employed to quantify the binding and activity relationship between PCDHA3 and these activators. Furthermore, structural studies using techniques like crystallography or cryo-electron microscopy would provide detailed insights into the interaction between PCDHA3 and the activators at an atomic level, guiding further refinement of the molecules. The goal of developing PCDHA3 activators would be to create tools for researchers to probe the functional roles of this particular protocadherin in cell adhesion processes, enhancing our understanding of cellular interactions in complex tissues such as the brain. This, in turn, would expand the knowledge base within the field of cellular biology and contribute to the broader scientific endeavor of deciphering the fundamental principles of cellular communication and network formation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound is an epigenetic modulator known to inhibit DNA methylation, potentially leading to increased PCDHA3 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A can alter chromatin structure and enhance gene expression, including PCDHA3. | ||||||
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
This synthetic estrogen can modulate gene expression through estrogen receptor signaling, potentially affecting PCDHA3 levels. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can lead to changes in gene expression, possibly impacting PCDHA3. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a phytoestrogen, may alter gene expression by acting on estrogen receptors or by inhibiting tyrosine kinases. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
This cAMP analog can mimic the effects of neural activity and potentially stimulate the expression of genes like PCDHA3. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor, potentially affecting gene expression patterns, including PCDHA3. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $385.00 $2654.00 | ||
Retinol, a form of vitamin A, is involved in gene regulation and neuronal differentiation, which could influence PCDHA3 levels. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
As a phosphodiesterase inhibitor, theophylline raises intracellular cAMP, which may impact neuronal gene expression. | ||||||
L-Methionine | 63-68-3 | sc-394076 sc-394076A sc-394076B sc-394076C sc-394076D sc-394076E | 25 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $37.00 $57.00 $151.00 $577.00 $1103.00 | ||
As an essential amino acid, methionine is important for methylation reactions and may influence epigenetic regulation of PCDHA3. | ||||||